
GC18177
WEHI-345
Also known as N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]pyridine-4-carboxamide
WEHI-345 is an inhibitor of receptor-interacting protein kinase 2 (RIPK2; IC50 = 130 nM in a kinase assay using human recombinant RIPK2)
ChemicalCAS1354825-58-3MW401.5FormulaC22H23N7O
- CAS number
- 1354825-58-3
- Molecular weight
- 401.5
- Formula
- C22H23N7O
- Solubility
- DMF: 2 mg/ml,DMSO: 2 mg/ml,Ethanol: slightly soluble
- InChIKey
- LEBSTCDZKUSVOY-UHFFFAOYSA-N
- Catalogue number
- GC18177
- Brand
- GLPBIO
Computed properties PubChem CID 56602554 · XLogP 2.3 · TPSA 112 Ų · H-bond donors 2
- XLogP
- 2.3
- TPSA
- 112 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 5
- Heavy atoms
- 30
SMILES CC1=CC=C(C=C1)C2=NN(C3=NC=NC(=C23)N)C(C)(C)CNC(=O)C4=CC=NC=C4
Computed descriptors from PubChem (CID 56602554), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il